Recursion's core technology is the Recursion Operating System (Recursion OS) — an end-to-end drug discovery and development platform that integrates phenomics, transcriptomics, proteomics, ADME data, and de-identified patient data into a continuously improving feedback loop. The platform spans >50 petabytes of proprietary biological and chemical data generated by a fully automated wet lab that uses robotics and computer vision to run millions of cell experiments per week. To handle this computational load, Recursion partnered with NVIDIA to build BioHive-2, biopharma's most powerful supercomputer. ML models trained on this infrastructure are used to rapidly identify novel drug targets and design optimized molecules for first-in-class and best-in-class therapeutics.